2024 OrthoPitch Winner!

2024 OrthoPitch Winner!

We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...
AAOS OrthoPitch 2024

AAOS OrthoPitch 2024

CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...
CytexOrtho on Capital Hill

CytexOrtho on Capital Hill

On May 11th, 2023 Dr Brad Estes, CytexOrtho Co-founder and CEO, traveled to Washington D.C. to sit on a panel about the state of osteoarthritis (OA) in the United States, and the need for additional funding to move scientific advances combating OA to the clinic. The...
Breakthrough Device Designation from the FDA

Breakthrough Device Designation from the FDA

  We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
In WRAL Techwire

In WRAL Techwire

CytexOrtho is in the news! WRAL Techwire featured a Startup Spotlight article about CytexOrtho on Monday, August 8th, 2022.  According to WRAL: “Startup Spotlight is a regular feature in WRAL Techwire, bringing attention to promising emerging companies across the...
In Medical Textiles

In Medical Textiles

Today we are pleased to announce that our novel cartilage regeneration implant is the lead story in the November issue of Medical Textiles. This feature references the publication in Science Advances, where CytexOrtho scientists demonstrate cartilage restoration in...